🔓 Unlock the full profile of Mahendra Joshi (Idrs Labs Private Limited), including verified contact details, financial insights, and professional associations.
See Mahendra Joshi Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: mah*****@idr******.com
Mobile: 80944*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Mahendra Joshi co-founded IDRS LABS PRIVATE LIMITED in January 2013 and currently serves as the Director of Technical Operations, playing a crucial role in the company's development and success.
- Prior to IDRS LABS, Mahendra held the position of Deputy Director for NCE Formulation Development at Aizant from February 2008 to December 2012, where significant contributions were made in novel drug formulation strategies.
- Experience includes serving as Assistant Manager in NCE Product Development at Dr. Reddy's Laboratories from February 2006 to January 2008, which involved overseeing key projects aimed at new chemical entity developments.
- Before that, tenure as Senior Research Associate at Wockhardt Ltd. from September 2005 to January 2006 was marked by participation in innovative research activities that advanced the company’s drug development portfolio.
- Mahendra also worked as a Research Scientist in Novel Drug Delivery Systems at Ranbaxy Research Laboratories from February 2002 to August 2005, contributing valuable insights into drug delivery technologies.
- Early career experience includes a role as Technical Trainee in Product Development Systems at Ohm Laboratories in New Jersey, USA, from July to December 2001, laying a solid foundation in pharmaceutical development practices.
- Throughout the career, a strong emphasis has been placed on integrating advanced research methodologies and operational efficiencies in drug formulation and development.
- Demonstrated leadership capabilities in various organizations have led to successful project outcomes and innovations that have influenced the biopharmaceutical industry.